Regulation of HIV-1 transcription by NF-IL6 in activated Jurkat T cells

被引:11
作者
Buckner, AE [1 ]
Tesmer, VM [1 ]
Bina, M [1 ]
机构
[1] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA
基金
美国国家卫生研究院;
关键词
HIV-1; LTR; promoter; LPS; PMA;
D O I
10.1016/S0168-1702(02)00110-7
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To examine the mechanism of HIV-1 regulation by NF-IL6 in activated human cells, we selected a Jurkat cell line that did not contain endogenous NF-IL6. In this cellular environment, we evaluated the effect of exogenous NF-IL6 on transcription mediated by native and deleted LTR sequences. In Jurkat cells stimulated with LPS and PMA, LTR-mediated transcription was enhanced by NF-IL6. The results of deletion studies revealed a central role for the basal LTR region and the TATA element in the LTR, in upregulation of reporter gene expression by NF-IL6 in activated cells. In the selected cellular environment, regulation of transcription by NF-IL6 was not evident in studies of promoter regions of other genes. The results implied that the basal region of HIV-1 LTR includes molecular properties that support activation of HIV-1 by NF-IL6 in stimulated cells. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:53 / 63
页数:11
相关论文
共 47 条
[1]   A NUCLEAR FACTOR FOR IL-6 EXPRESSION (NF-IL6) IS A MEMBER OF A C/EBP FAMILY [J].
AKIRA, S ;
ISSHIKI, H ;
SUGITA, T ;
TANABE, O ;
KINOSHITA, S ;
NISHIO, Y ;
NAKAJIMA, T ;
HIRANO, T ;
KISHIMOTO, T .
EMBO JOURNAL, 1990, 9 (06) :1897-1906
[2]   IL-6 AND NF-IL6 IN ACUTE-PHASE RESPONSE AND VIRAL-INFECTION [J].
AKIRA, S ;
KISHIMOTO, T .
IMMUNOLOGICAL REVIEWS, 1992, 127 :25-50
[3]   SERUM-INDUCED, TPA-INDUCED, AND RAS-INDUCED EXPRESSION FROM AP-1/ETS-DRIVEN PROMOTERS REQUIRES RAF-1 KINASE [J].
BRUDER, JT ;
HEIDECKER, G ;
RAPP, UR .
GENES & DEVELOPMENT, 1992, 6 (04) :545-556
[4]  
BUCKNER A, 2000, THESIS PURDUE U
[5]   Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection [J].
Chun, TW ;
Carruth, L ;
Finzi, D ;
Shen, XF ;
DiGiuseppe, JA ;
Taylor, H ;
Hermankova, M ;
Chadwick, K ;
Margolick, J ;
Quinn, TC ;
Kuo, YH ;
Brookmeyer, R ;
Zeiger, MA ;
BarditchCrovo, P ;
Siliciano, RF .
NATURE, 1997, 387 (6629) :183-188
[6]   Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J].
Chun, TW ;
Stuyver, L ;
Mizell, SB ;
Ehler, LA ;
Mican, JAM ;
Baseler, M ;
Lloyd, AL ;
Nowak, MA ;
Fauci, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13193-13197
[7]  
DAVYDOV IV, 1995, J IMMUNOL, V155, P5273
[8]   MOLECULAR AND FUNCTIONAL INTERACTIONS OF TRANSCRIPTION FACTOR USF WITH THE LONG TERMINAL REPEAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
DIFAGAGNA, FD ;
MARZIO, G ;
GUTIERREZ, MI ;
KANG, LY ;
FALASCHI, A ;
GIACCA, M .
JOURNAL OF VIROLOGY, 1995, 69 (05) :2765-2775
[9]  
DOYLE K, 1994, J BIOL CHEM, V269, P12099
[10]   HUMAN TRANSCRIPTION FACTOR USF STIMULATES TRANSCRIPTION THROUGH THE INITIATOR ELEMENTS OF THE HIV-1 AND THE AD-ML PROMOTERS [J].
DU, H ;
ROY, AL ;
ROEDER, RG .
EMBO JOURNAL, 1993, 12 (02) :501-511